Currently, XORTX Therapeutics Inc’s (XRTX) stock is trading at $1.05, marking a fall of -17.33% from last night’s close. At this price, the stock is -85.00% below its 52-week high of $7.00 and -0.95% above its 52-week low of $1.06. Based on the past 30-day period, the stock price is -45.25% below the high and +15.28% above the low.
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, XRTX’s SMA-200 is $1.8874.
XRTX’s price to book ratio for the most recent quarter was 1.43, resulting in an 1.59 price to cash per share for the period.
How does XORTX Therapeutics Inc (XRTX) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
XORTX Therapeutics Inc (NASDAQ: XRTX) Ownership Details
I will give a breakdown of the key shareholders in XORTX Therapeutics Inc (XRTX). Recent figures show that the company’s insiders hold 3.02% of shares. A total of 8 institutional investors hold shares in the company, making 6.03% of its stock and 6.22% of its float.
Sep 30, 2024, it was reported that the Company’s largest institutional holder is UBS Group AG holding total of 18.78 shares that make 0.54% of the company’s total number of shares and are currently priced at 18028.0.
The securities firm National Bank of Canada/FI holds 3.44 shares of XRTX, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.10%, and the holding percentage of shares is valued at 3302.0.
An overview of XORTX Therapeutics Inc’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests XORTX Therapeutics Inc (XRTX) traded 239,661 shares per day, with a moving average of $1.1735 and price change of -0.2100. With the moving average of $1.2373 and a price change of -0.4499, about 106,239 shares changed hands on average over the past 50 days. Finally, XRTX’s 100-day average volume is 1,876,140 shares, alongside a moving average of $1.4695 and a price change of -0.4150.
